Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of “Hold” from Brokerages

Posted by George Bondi on Sep 24th, 2026

Shares of Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) have been assigned an average rating of “Hold” from the twenty-two ratings firms that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and eleven have issued a buy rating on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $69.6316.

Several equities research analysts recently weighed in on TEM shares. TD Cowen restated a “buy” rating on shares of Tempus AI in a research report on Wednesday, July 15th. Wolfe Research started coverage on Tempus AI in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Rothschild & Co Redburn assumed coverage on Tempus AI in a research report on Tuesday, September 8th. They set a “neutral” rating and a $67.00 price objective for the company. Freedom Capital upgraded shares of Tempus AI to a “hold” rating in a report on Tuesday, June 30th. Finally, Stifel Nicolaus reduced their target price on shares of Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research report on Monday, August 3rd.

Get Our Latest Analysis on Tempus AI

Insider Buying and Selling at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 200,000 shares of Tempus AI stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $80.57, for a total transaction of $16,114,000.00. Following the completion of the transaction, the chief executive officer directly owned 809,631 shares in the company, valued at approximately $65,231,969.67. This trade represents a 19.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Nadja West sold 3,000 shares of the business’s stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $69.00, for a total value of $207,000.00. Following the completion of the sale, the director directly owned 31,981 shares in the company, valued at approximately $2,206,689. This represents a 8.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,240,499 shares of company stock valued at $73,096,282 over the last three months. 24.26% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TEM. EMC Capital Management bought a new stake in Tempus AI in the second quarter worth $29,000. Whittier Trust Co. increased its holdings in shares of Tempus AI by 190.0% during the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock valued at $41,000 after acquiring an additional 570 shares in the last quarter. Global Assets Advisory LLC bought a new position in shares of Tempus AI during the first quarter valued at $46,000. CoreCap Advisors LLC raised its position in shares of Tempus AI by 293.4% in the 2nd quarter. CoreCap Advisors LLC now owns 1,019 shares of the company’s stock worth $59,000 after purchasing an additional 760 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. purchased a new position in shares of Tempus AI in the 4th quarter worth about $70,000. Institutional investors own 24.22% of the company’s stock.

Tempus AI Price Performance

Shares of NASDAQ TEM opened at $76.59 on Thursday. Tempus AI has a 1 year low of $40.77 and a 1 year high of $104.32. The company has a debt-to-equity ratio of 3.06, a current ratio of 3.30 and a quick ratio of 3.16. The company’s 50-day moving average is $58.39 and its 200 day moving average is $53.43. The stock has a market capitalization of $13.82 billion, a P/E ratio of -53.19 and a beta of 3.72.

Tempus AI (NASDAQ:TEM – Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.10. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The business had revenue of $382.49 million for the quarter, compared to analysts’ expectations of $379.69 million. During the same period in the previous year, the firm posted ($0.22) EPS. The business’s revenue was up 21.6% on a year-over-year basis. On average, sell-side analysts expect that Tempus AI will post -1.38 earnings per share for the current year.

About Tempus AI

(Get Free Report)

Tempus AI, Inc is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies.

Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management.

The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States.